Sunshine Biopharma financials at a glance
| Year | Year | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.02M | $0.07M | $0.23M | $4.35M | $24.09M | $0.00M |
| GM % | Gross Margin % |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 47.68% | 63.80% | 48.42% | 39.04% | 34.61% | 0.00% |
| OM | Operating Margin |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -199.60% | -19.86% | 0.00% |
| EPS | Earnings Per Share |
|
$0.00 | |||||||||||||||
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sha. | Shares |
|
0.02m | 0.08m | 0.08m | 0.13m | 0.14m | 0.17m | 0.34m | 1.72m | 2.3m | 4.28m | 28.71m | 1.66m | 2.59m | 7.13m | 0m | 0.99m |
| OCF | Operating Cash Flow |
|
$-1.61M | $-0.35M | $-0.30M | $-0.39M | $-0.56M | $-0.54M | $-0.87M | $-0.31M | $-0.54M | $-0.51M | $-0.50M | $-0.66M | $-1.83M | $-5.25M | $-8.78M | $0.00M |
| FCF | Free Cash Flow |
|
$0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $-0.53M | $0.00M | $0.00M | $0.00M | $-5.44M | $-8.86M | $0.00M |
| FCFS | Free Cash Flow Per Share |
|
$-27.17 | $-4.67 | $-3.85 | $-3.16 | $-4.08 | $-3.26 | $-4.88 | $-0.30 | $-0.25 | $-0.17 | $-0.05 | $-0.00 | $-0.70 | $-0.37 | $-39.30 | $0.00 |